(CercleFinance.com) – The European Medicines Agency (EMA) has issued a positive opinion on the first two variant-adapted COVID-19 booster vaccines: Comirnaty and Spikevax, by BioNTech-Pfizer and Moderna respectively.
Stella Kyriakides, Commissioner for Health and Food Safety, said: ‘Today’s positive opinions from the European Medicines Agency on the first two variant-tailored mRNA vaccines, from BioNTech-Pfizer and Moderna , are important to protect Europeans against the likely risk of waves of infections in autumn and winter. We have to be prepared for another winter with COVID-19’.
‘We will now proceed with an accelerated authorization of these vaccines to ensure that they can be deployed quickly across the EU.’
‘Subject to the scientific assessment of the EMA, we are also expecting an opinion on the adapted vaccines Omicron BA.4 and BA.5 in the coming weeks’ adds Stella Kyriakides.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
